期刊文献+

扶正抑癌方含药血清对结肠癌Lovo细胞TGF-/Smad信号转导通路的影响及意义 被引量:5

Expression and Significance of Fuzheng Yi′ai Decoction Drug Serum on TGF-β/Smad Signal Transduction Pathway in Colorectal Cancer Lovo Cells
下载PDF
导出
摘要 目的通过观察扶正抑癌方含药血清对结肠癌Lovo细胞TGF-β/smad信号转导通路中TGF-β1、Smad3和p-Smad3蛋白表达的影响,明确扶正抑癌方抑制结肠癌细胞间质化转变的作用机制。方法 Lovo细胞体外培养,制备大鼠不同浓度含药血清后,MTT法测定不同浓度含药血清对细胞增殖的影响,以5-Fu作为阳性对照;通过Western blot检测TGF-β1、Smad3和p-Smad3蛋白的表达。结果大剂量含药血清组24 h对Lovo细胞抑制率较中剂量、小剂量组作用更加明显,差异具有统计学意义(P<0.01)。Western blot检测结果表明扶正抑癌方含药血清可以下调Lovo细胞TGF-β1、Smad3和p-Smad3的蛋白表达,与正常组和空白组相比,差异具有统计学意义(P<0.05)。结论扶正抑癌方含药血清可能通过下调TGF-β/smad信号转导通路中TGF-β1、Smad3和p-Smad3的蛋白表达,抑制Lo-vo细胞间质化转变。 Objective To discuss the mechanism of drug serum of Fuzheng Yi'ai decoction on epithelial- mesenchymal transition(EMT) in human colon cancer cell line Lovo by investigating the expression of TGF β1 and Smad3 and p-Smad3 protein level of TGF-β/Smad signal transduction pathway. Methods The proliferation effect on Lovo cells treated with various concentrations of drug serum was detected by MTT method. A group treated by 5-Fu was used as positive control. Then the expression of TGF-β1 and Srnad3 and p-Smad3 protein were detected by Western blot assay. Results According to the results of MTT test,the large concentrations of Fuzheng Yi'ai decoction drug serum restrained the cells proliferation effect was obvious at 24 hours,compared with the median group and small concentration group (P〈 0. 01 );the Western blot result revealed that the expressions of TGF-β1 ,Smad3 and p-Smad3 protein in drug serum group were down-regulated in comparison with the blank group and normal group (P〈 0.05). Conclusion The drug serum of Fuzheng Yi'ai decoction can inhibit the EMT of Lovo cell correlated with the decreasing expression of TGF-β1. Smad3 and p-Smad3 protein level of TGF-β/Smad signal transduction pathway.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第10期1163-1165,共3页 Cancer Research on Prevention and Treatment
基金 上海市教委重点学科建设资助项目(J50301)
关键词 扶正抑癌方 结肠癌细胞 TGF-Β/SMAD信号通路 TGF—β1 SMAD3 p-Smad3 Fuzheng Yi' ai decoction Cell line Lovo TGF-β/Smad signal transduction pathway TGF-β1 Smad3 p-Smad3
  • 相关文献

参考文献8

  • 1Saika S,Kono Saika S,Ohnishi Y,et al. Smad3 signaling is re quired for epithelial mesenchymal transition of lens epilhcliuin after injury[J]. Am J Pathol,2004, 164 (2) :651-63.
  • 2Wendt MK,Allington TM,Schiemann WP. Mechanisms of the epithelial mcsenchymal transition by TGF β[J]. Future Oncol, 2009,5(8) : 1145 68.
  • 3Peinado H,Quinlanilla M,Cano A. Transforming growth fac tot hera 1 induces snail transcription factor in epilhelial cell lines mechanisms for epithelial mesenchymal transitions [J]. J Biol Chem,2003,278(23) :21113-23.
  • 4Vincent T,Neve EP,Johnson JR,et al. A SNA1L1 SMAD3/4 transcriptional repressor complex promotes TGF β mediated epithelial-mesenchymal transition [J]. Nat Cell Biol, 2009, 11 (8):943-50.
  • 5Sato M, Muragaki Y, Saika S, el al. Targeted disruption of TGF β1/Smad3 signaling protects against renal tubuloimersti- lial fibrosis induced by unilateral ureleral obstruction[J].J Clin lnvest,2003.112(10) : 1486-94.
  • 6Munoz N, Back JY,Grady W M. TGF-β has paradoxical and contexl dependent effects on proliferation and anoikis in human colorectal cancer cell lines [J], Growth Factors,2008,26(5):254-62.
  • 7李素云,周春仙,顾燕频,袁宝萍,卫洪昌.扶正抑癌方含药血清对结肠癌lovo细胞E-cad、N-cad和Snail蛋白表达的影响[J].中国肿瘤,2011,20(9):690-693. 被引量:9
  • 8李素云,周春仙,卫洪昌.扶正抑癌方含药血清对结肠癌lovo细胞侵袭转移能力及TGF-β_1与TβRⅡ蛋白表达的影响[J].上海中医药大学学报,2010,24(1):68-71. 被引量:13

二级参考文献20

  • 1盛学仕,张瑞芳,庞慧芳,章忱,卫洪昌.扶正抑癌方对人结肠癌细胞裸鼠肝转移的影响[J].上海中医药大学学报,2005,19(4):39-41. 被引量:12
  • 2Elliott RL, Blobe GC . Role of transforming growth factor beta in human cancer[ J ]. J Clin Oncol,2005,23 (9) :2078-2093.
  • 3Robson H, Anderson E, James RD, et al. Transforming growth factor beta 1 expression in human colorectal turnouts: an independent prognostic marker in a subgroup of poor prognosis patients[ J]. Br J Cancer, 1996,74 ( 5 ) :753-758.
  • 4Biswas S, Chytil A, Washington K, et al. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer[ J]. Cancer Res,2004,64(14) :4687- 4692.
  • 5Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha ras oncogene product in normal, benign, and malinant human pancrestic tissue[ J]. Hum Pathol, 1990,21 (6) :607-612.
  • 6Deryuck R, Akhurst R J, Balmain A. TGF-beta signaling in tumor suppression and cancer progression [ J]. Nat Genet,2001,29 (2) : 117-129.
  • 7Valcourt U, Kowanetz M, Niimi H, et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogra epithelial-mesenchymal cell transition [ J ]. Mol Biol Cell,2005,16 (4) : 1987-2002.
  • 8Lebrin F, Goumans M J, Jonker L, et al. Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduetion [ J]. EMBO J,2004 ,23(20) : 4018-4028.
  • 9Chen MI, Pittet M J, Gorelik L, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo [ J]. Cancer Res,2006,66 ( 17 ) :8617-8624.
  • 10Grady WM, Myeroff LL, Swinler SE, et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers [ J ]. Cancer Res, 1999,59 ( 2 ) :320-324.

共引文献18

同被引文献122

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部